Geneoscopy honored by goldman sachs for entrepreneurship

St. louis, oct. 13, 2021 /prnewswire/ – geneoscopy inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced that goldman sachs (nyse: gs) is recognizing the company's co-founder and ceo, andrew barnell, as one of the 100 most intriguing entrepreneurs of 2021 at its builders + innovators summit in healdsburg, california. goldman sachs selected barnell as one of 100 entrepreneurs from multiple industries to be honored at the two-day event.
GS Ratings Summary
GS Quant Ranking